1
|
Huber M, Busch AK, Stalder-Ochsner I, Flammer AJ, Schmid-Mohler G. Medication adherence in adults after hospitalization for heart failure: A cross-sectional study. Int J Cardiol Cardiovasc Risk Prev 2024; 20:200234. [PMID: 38299126 PMCID: PMC10828571 DOI: 10.1016/j.ijcrp.2023.200234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Revised: 12/19/2023] [Accepted: 12/21/2023] [Indexed: 02/02/2024]
Abstract
Background Medication non-adherence in heart failure (HF) leads to increased mortality, morbidity and healthcare costs. However, no study has investigated HF patients' post-hospitalization medication non-adherence in Switzerland. Objectives Our primary aim was to assess the prevalence of post-discharge medication non-adherence in patients with HF. A secondary objective was to identify differences between fully and partially adherent patients regarding selected unplanned therapy-related inpatient/outpatient cardiology visits. Methods A non-experimental cross-sectional study was applied. The prevalence of medication adherence was assessed with a German-translated version of the Medication Adherence Report Scale (MARS-5) and analyzed descriptively. Differences between adherent and partially adherent patients' numbers of medications, dosing per day and 180-day unplanned inpatient stays or cardiology outpatient visits were explored. Results Of 153 recruited patients, 72 participated in the survey. Of these, 26.4 % were not fully adherent. Their most common reason was forgetfulness (23.7 %). There were no significant group differences regarding therapy-related variables or 180-day unplanned cardiology stays/visits. Conclusions Considering that over one-quarter of surveyed HF patients were not fully medication adherent, Swiss cardiology nurses need to be sensitized to this issue and trained in adherence-enhancing interventions. Reaching acceptable adherence levels in patients with HF will require further research and action.
Collapse
Affiliation(s)
- Manuela Huber
- Educational Center for Health and Social, Weinfelden, Switzerland
- Clinic for General, Visceral, Transplant, Vascular and Thoracic Surgery, Cantonal Hospital St. Gallen, Switzerland
| | - Ada Katrin Busch
- Institute of Nursing, ZHAW School of Health Science, Winterthur, Switzerland
| | - Irene Stalder-Ochsner
- Department of Cardiology, University Heart Center, University Hospital Zurich, Switzerland
| | - Andreas J. Flammer
- Department of Cardiology, University Heart Center, University Hospital Zurich, Switzerland
| | - Gabriela Schmid-Mohler
- Center of Clinical Nursing Science, University Hospital Zurich, Switzerland
- Department of Pulmonology, University Hospital Zurich, Switzerland
| |
Collapse
|
2
|
Yosef T, Nureye D, Tekalign E, Assefa E, Shifera N. Medication Adherence and Contributing Factors Among Type 2 Diabetes Patients at Adama Hospital Medical College in Eastern Ethiopia. SAGE Open Nurs 2023; 9:23779608231158975. [PMID: 36844422 PMCID: PMC9944187 DOI: 10.1177/23779608231158975] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Revised: 12/28/2022] [Accepted: 02/04/2023] [Indexed: 02/22/2023] Open
Abstract
Introduction Good glycemic control and preventing early complications are the ultimate targets of diabetes management, which depends on patients' adherence to regimens. Even though highly potent and effective medications have been developed and manufactured with astonishing advancement over the past few decades, excellent glycemic control has remained elusive. Objective This study aimed to assess the magnitude and factors associated with medication adherence among type 2 diabetes (T2D) patients on follow-up at Adama Hospital Medical College (AHMC) in East Ethiopia. Methods A hospital-based cross-sectional study was conducted among 245 T2D patients on follow-up at AHMC from March 1 to March 30, 2020. Medication adherence reporting scale-5 (MARS-5) was utilized to collect information regarding patients' medication adherence. The data were entered and analyzed using SPSS (Statistical Package for Social Sciences) version 21. The level of significance was declared at a p-value of < .05. Results Of the 245 respondents, the proportion of respondents who adhere to diabetes medication was 29.4%, 95% CI [confidence interval] (23.7%-35.1%). After adjusting for khat chewing and adherence to blood glucose testing as confounding factors, being married (AOR [adjusted odds ratio] = 3.43, 95%CI [1.27-4.86]), government employee (AOR = 3.75, 95%CI [2.12-7.37]), no alcohol drinking (AOR = 2.25, 95%CI [1.32-3.45]), absence of comorbidity (AOR = 1.49, 95%CI [1.16-4.32]), and having diabetes health education at health institution (AOR = 3.43, 95%CI [1.27-4.86]) were the factors associated with good medication adherence. Conclusion The proportion of T2D patients who adhere to medication in the study area was remarkably low. The study also found that being married, government employee, no alcohol drinking, absence of comorbidity, and having diabetes health education at a health institution were the factors associated with good medication adherence. Therefore, imparting health education on the importance of diabetes medication adherence by health professionals at each follow-up visit should be considered. Besides, awareness creation programs regarding diabetes medication adherence should be considered using mass media (radio and television).
Collapse
Affiliation(s)
- Tewodros Yosef
- School of Public Health, College of Medicine and Health Sciences,
Mizan-Tepi
University, Mizan Teferi, Ethiopia,Tewodros Yosef, School of Public Health,
College of Medicine and Health Sciences, Mizan-Tepi University, Mizan Teferi,
Ethiopia.
| | - Dejen Nureye
- School of Pharmacy, College of Medicine and Health Sciences,
Mizan-Tepi
University, Mizan Teferi, Ethiopia
| | - Eyob Tekalign
- Department of Medical Laboratory Science, College of Medicine and
Health Sciences, Mizan-Tepi
University, Mizan Teferi, Ethiopia
| | - Elias Assefa
- School of Public Health, College of Medicine and Health Sciences,
Mizan-Tepi
University, Mizan Teferi, Ethiopia
| | - Nigusie Shifera
- School of Public Health, College of Medicine and Health Sciences,
Mizan-Tepi
University, Mizan Teferi, Ethiopia
| |
Collapse
|
3
|
Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence. Br J Clin Pharmacol 2020; 86:1281-1288. [PMID: 31823381 PMCID: PMC7319010 DOI: 10.1111/bcp.14193] [Citation(s) in RCA: 158] [Impact Index Per Article: 39.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Revised: 10/19/2019] [Accepted: 11/04/2019] [Indexed: 02/06/2023] Open
Abstract
Aims This study aimed to establish the psychometric properties of a questionnaire measure of patients' adherence to medications to elicit patients' report of medication use in a variety of clinical samples. The reliability and validity were assessed in patients with hypertension. Additional analyses were performed on other patient groups. Methods Using a cross‐sectional study design, a 10‐item version of the Medication Adherence Report Scale (©Professor Rob Horne) was piloted in two samples of patients receiving treatment for hypertension (n = 50 + 178), asthma (n = 100) or diabetes (n = 100) at hospital outpatient or community clinics in London and the south‐east of England. Following principal components analysis, five items were retained to form MARS‐5 (©Professor Rob Horne). Evaluation comprised internal reliability, test‐retest reliability, criterion‐related validity (relationship with blood pressure control) and construct validity (relationship with patients' beliefs about medicines). Results The MARS‐5 demonstrated acceptable reliability (internal and test‐retest) and validity (criterion‐related and construct validity) in these patient groups. Internal reliability (Cronbach's α) ranged from 0.67 to 0.89 across all patient groups; test‐retest reliability (Pearson's r) was 0.97 in hypertension. Criterion‐related validity was established with more adherent hypertension patients showing better blood‐pressure control (χ2 = 4.24, df = 1, P < .05). Construct validity with beliefs about medicines was demonstrated with higher adherence associated with stronger beliefs in treatment necessity and lower treatment concerns. Conclusions The MARS‐5 performed well on several psychometric indicators in this study. It shows promise as an effective self‐report tool for measuring patients' reports of their medication use across a range of health conditions.
Collapse
Affiliation(s)
- Amy Hai Yan Chan
- Department of Practice and Policy, Centre for Behavioural Medicine, Department of Practice and Policy, UCL School of Pharmacy, London, UK
| | - Rob Horne
- Department of Practice and Policy, Centre for Behavioural Medicine, Department of Practice and Policy, UCL School of Pharmacy, London, UK
| | | | - Claudia Chisari
- Department of Practice and Policy, Centre for Behavioural Medicine, Department of Practice and Policy, UCL School of Pharmacy, London, UK
| |
Collapse
|
4
|
Vluggen S, Hoving C, Schaper NC, De Vries H. Psychological predictors of adherence to oral hypoglycaemic agents: an application of the ProMAS questionnaire. Psychol Health 2019; 35:387-404. [PMID: 31588778 DOI: 10.1080/08870446.2019.1672873] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Objectives: This study aimed to identify psychological predictors of oral hypoglycaemic agent (OHA) adherence and to compare adherence rates between a novel and well-known instrument, i.e. the Probabilistic Medication Adherence Scale (ProMAS) and Medication Adherence Report Scale (MARS-5).Design and main outcome measures: A longitudinal study design was applied with surveys at baseline and 6-month follow-up. At baseline, OHA adherence using the ProMAS and MARS-5, socio-cognitive determinants and demographics were assessed. At follow-up, the ProMAS was applied as outcome measure, on which socio-cognitive determinants and demographics were regressed using linear regression analysis.Results: The baseline and follow-up sample included 304 and 231 participants, respectively. When applying cut-off points of ≥15 for the ProMAS and ≥23 for the MARS-5, 47.4 and 89.5% adhered to their OHAs. Consistent predictors of better adherence comprised a low education, lower severity perceptions, and higher self-efficacy and intention. After correcting for baseline adherence, a low education and higher self-efficacy remained significant adherence predictors.Conclusions: Compared to the MARS-5, ProMAS data was less skewed, similar to objectively collected data, and yielded insights in a broader spectrum of (non)-adherence behaviours. Results stress the need for adherence improving interventions which particularly should target higher educated patients and patients with low self-efficacy, low intention and high severity perceptions.
Collapse
Affiliation(s)
- Stan Vluggen
- Department of Health Promotion, School CAPHRI, Maastricht University, Maastricht, the Netherlands
| | - Ciska Hoving
- Department of Health Promotion, School CAPHRI, Maastricht University, Maastricht, the Netherlands
| | - Nicolaas C Schaper
- Department of Endocrinology and Internal Medicine, School CAPHRI, University Medical Centre (MUMC+), Maastricht, the Netherlands
| | - Hein De Vries
- Department of Health Promotion, School CAPHRI, Maastricht University, Maastricht, the Netherlands
| |
Collapse
|
5
|
SOLE Study Group. Translation and initial validation of the Medication Adherence Report Scale (MARS) in Italian patients with Crohn's Disease. Dig Liver Dis 2019; 51:640-7. [PMID: 30409692 DOI: 10.1016/j.dld.2018.09.026] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/08/2018] [Revised: 09/20/2018] [Accepted: 09/21/2018] [Indexed: 12/11/2022]
Abstract
The MARS-5 (Medication Adherence Report Scale) was developed in English. The aim of this project was to analyse the MARS-5I (© Prof Rob Horne) psychometric properties and to identify whether its Italian translation is suitable for assessing medication adherence in Crohn Disease (CD) Italian patients. The MARS was translated and linguistically validated in Italian. The MARS-5I was used for evaluating medication adherence in the SOLE study, conducted in Italy on 552 subjects with CD. In order to un-bias the questionnaire results from the effects of treatment change and/or effectiveness, the analyses were performed on the 277 patients whose disease activity remained stable, selected among the 371 patients who maintained the same treatment between two consecutive visits. Internal consistency was high (Cronbach's alpha of 0.86). Pearson's correlation coefficient was 0.50 (p<0.001) and 0.86 (p<0.001- outliers removed), indicating satisfactory test-retest. MARS 5I scores were not correlated with Treatment Satisfaction Questionnaire for Medication but a small and statistically significant correlation was shown with physician-evaluated medication adherence, indicating convergent validity. MARS-5I, the Italian translation of the English MARS, showed satisfactory internal consistency and test-retest, and a low but statistically significant convergent validity. We confirmed the utility of this tool in patients with CD.
Collapse
|
6
|
Lin CY, Chen H, Pakpour AH. Correlation between adherence to antiepileptic drugs and quality of life in patients with epilepsy: A longitudinal study. Epilepsy Behav 2016; 63:103-108. [PMID: 27588360 DOI: 10.1016/j.yebeh.2016.07.042] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/09/2016] [Revised: 07/27/2016] [Accepted: 07/28/2016] [Indexed: 12/18/2022]
Abstract
OBJECTIVE This study aimed to investigate whether the score of self-reported medication adherence using the Medication Adherence Report Scale (MARS-5) correlates with the serum level of antiepileptic medication, as well as whether the MARS-5 score can predict the quality of life (QoL) in patients with epilepsy. METHODS A longitudinal study was carried out. The patients with epilepsy who were prescribed a minimum of one antiepileptic drug were recruited (n=807). Each participant completed a background information sheet and the MARS-5 at baseline, followed by the Liverpool Seizure Severity Scale (LSSS) and Quality of Life in Epilepsy (QOLIE-31) questionnaire at 18-month follow-up. In addition, the serum level of antiepileptic medications was measured at the follow-up. RESULTS The MARS-5 score was negatively associated with the LSSS score (B=-0.089, SE=0.009, p<0.001) and positively correlated with the serum level of antiepileptic medications (B=3.200, SE=0.416, p<0.001), after adjusting for demographics and clinical characteristics. The serum level of antiepileptic drugs was significantly correlated with the overall QOLIE-31 score (B=3.118, SE=1.417, p=0.03). The MARS-5 score was significantly correlated with the overall QOLIE-31 scores and all the scores in the subcategories. In addition, the MARS-5 score was in line with the correlation between the LSSS and QOLIE-31 scores (Z=4.20, p<0.001) and between serum antiepileptic medication levels and QOLIE-31 score (Z=3.98, p<0.001). CONCLUSIONS The MARS-5 score can predict the QoL in patients with epilepsy for up to 18months. Therefore, healthcare providers may predict the QoL and drug adherence using the MARS-5 score, in order to design personalized interventions.
Collapse
Affiliation(s)
- Chung-Ying Lin
- Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong
| | - Hui Chen
- School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW 2007, Australia
| | - Amir H Pakpour
- Social Determinants of Health Research Center, Qazvin University of Medical Sciences, Shahid Bahounar BLV, Qazvin 3419759811, Iran.
| |
Collapse
|
7
|
Abstract
OBJECTIVE To assess the reliability of the Medication Adherence Report Scale (MARS-5) for assessing adherence in clinical practice and research. METHODS Prospective cohort study following electronically measured inhaled corticosteroids (ICS) adherence for 1 year in 2-13-year-old children with persistent asthma. The relationship between electronically measured adherence and MARS-5 scores (ranging from 5 to 25) was assessed by Spearman's rank correlation coefficient. A ROC (receiver operating characteristic) curve was performed testing MARS-5 against electronically measured adherence. Sensitivity, specificity, positive and negative likelihood ratios of the closest MARS-5 cut-off values to the top left-hand corner of the ROC curve were calculated. RESULTS High MARS scores were obtained (median 24, interquartile range 22-24). Despite a statistically significant correlation between MARS-5 and electronically assessed adherence (Spearman's rho = 0.47; p < 0.0001), there was considerable variation of adherence rates at every MARS-5 score. The area under the ROC curve was 0.7188. A MARS-5 score ≥23 had the best predictive ability for electronically assessed adherence, but positive and negative likelihood ratios were too small to be useful (1.65 and 0.27, respectively). CONCLUSIONS Self-report using MARS-5 is too inaccurate to be a useful measure of adherence in children with asthma, both in clinical practice and in research.
Collapse
Affiliation(s)
- Patricia W Garcia-Marcos
- a Deparment of General Pediatrics, Arrixaca University Children's Hospital , University of Murcia , Murcia , Spain.,b Princess Amalia Children's Center , Isala Hospital , Zwolle , The Netherlands
| | - Paul L P Brand
- b Princess Amalia Children's Center , Isala Hospital , Zwolle , The Netherlands.,c UMCG Postgraduate School of Medicine , University Medical Center, University of Groningen , The Netherlands
| | - Adrian A Kaptein
- d Unit of Psychology , Leiden University Medical Center , Leiden , The Netherlands
| | - Ted Klok
- b Princess Amalia Children's Center , Isala Hospital , Zwolle , The Netherlands.,e Department of Paediatric Pulmonology and Allergology , Wilhelmina Children's Hospital, University Medical Centre Utrecht , The Netherlands
| |
Collapse
|